[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Label Free Detection Market by Product & Service (Instruments, Consumables (Biosensor Chips, Microplates), Software), Technology (Surface Plasmon Resonance), Application (Hit Confirmation, Lead Generation), End User (Pharma, CROs) & Region – Global Forecast to 2028

July 2023 | 251 pages | ID: LFF83DC121FEN
MarketsandMarkets

US$ 4,950.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global label-free detection market is projected to reach USD 863 million by 2028 from USD 570 million in 2023, at a CAGR of 8.7% during the forecast period of 2023 to 2028. The growth of this market can be attributed to the rising industry-academia collaborations for research. For instance, In June 2023, Waters Corporation announced a multi-year research collaboration with Princeton University that will enable scientists, faculty, and students to work together to bring their diverse skills and backgrounds to solve complex challenges in biochemistry and materials science. Under the new agreement, the Waters-Princeton collaboration will bring together academic and industry researchers to tap into knowledge and expertise from various scientific domains and disciplines to identify and solve problems that matter. One such research project will focus on novel media for purification to help advance drug development and discovery.

“The biosensor chips segment accounted for the largest share by consumables during the forecast period”

In 2022, biosensor chips segment accounted for the largest share by consumables in the global label-free detection market. Biosensors are important tools in the fields of biochemistry and biomedical engineering because they provide a platform for the detection of various analytes. Currently, label-free biosensors are widely used in proteomics and biomolecular interaction studies, as the detection of the chemical or biological agent by the transducer does not rely on dyes, enzymes, or radiolabels. Conventionally, many small molecules are detected by chromatographic methods, which are usually costly, bulky, and require expertise. Biosensors offer a cheaper and faster alternative. Some advantages of biosensors over classical methods for small-molecule detection include real-time monitoring, high specificity, fast response times, reduced consumption of organic solvents and sample manipulation, portability, compactness, and easy operation.

“Europe: The second largest region in the label-free detection market”

Europe accounted for the second-largest market for label-free detection market after North America. The European label-free detection market has witnessed significant growth in recent years, driven by various factors that have propelled its expansion. Europe is at the forefront of developing and adopting emerging technologies in the field of label-free detection market. This includes advancements in label-free detection technologies. The adoption of these innovative technologies accelerates the progress of viral vector and plasmid DNA manufacturing research and expands its applications. Additionally, Europe offers comprehensive training and education programs in label-free detection technologies. Universities, research institutes, and organizations provide funding, and conferences to enhance the knowledge and skills of scientists and researchers. The availability of funding promotes the adoption and utilization of of label-free detection technologies in Europe.

The primary interviews conducted for this report can be categorized as follows:
  • By Respondent: Supply Side- 80% and Demand Side 20%
  • By Designation: C-level - 55%, D-level - 20%, and Others - 25%
  • By Region: North America -45%, Europe -20%, Asia-Pacific -25%, Latin America and Middle East & Africa- 10%
List of Companies Profiled in the Report:
  • Danaher (US)
  • Sartorius AG (Germany)
  • Waters Corporation (US)
  • PerkinElmer, Inc. (US)
  • AMETEK, Inc. (US)
  • HORIBA, Ltd. (Japan)
  • Spectris (UK)
  • METTLER TOLEDO International Inc., (US)
  • Agilent Technologies, Inc. (US)
  • Shimadzu Corporation (Japan)
  • Hitachi High-Tech Corporation (Japan)
  • Attana AB (Sweden)
  • Bruker (US)
  • NanoTemper Technologies GmbH (Germany)
  • Affinitй Instruments (Canada)
  • Biosensing Instrument (US)
  • Unchained Labs (US)
  • BioNavis Ltd. (Finland)
  • Carterra, Inc. (US)
  • Nicoya (Canada)
  • BiOptix Analytical LLC (US)
  • Plexera Bioscience (US)
  • XanTec Bioanalytics GmbH (Germany)
  • lino Biotech AG (Switzerland)
  • KEP Technologies (France)
Research Coverage:

This report provides a detailed picture of the label-free detection market. It aims at estimating the size and future growth potential of the market across different segments such as the product & service, technology, application, end user and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles recent developments and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges

The report provides insights on the following pointers:
  • Analysis of key drivers (Introduction of technologically advanced products, growing number of drug discovery programs through academic-industrial partnerships and high sensitivity of label-free technologies), restraints (High cost of instruments), opportunities (Growing life science research activities in emerging markets), and challenges (Shortage of skilled professionals) influencing the growth of the market.
  • Product and Service Development/Innovation: Detailed insights on newly launched products and technological assessment of the label-free detection market
  • Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the label-free detection market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies and products offerings of leading players like Danaher (US), Sartorius AG (Germany), Waters Corporation (US), PerkinElmer, Inc. (US), AMETEK, Inc. (US), HORIBA, Ltd. (Japan), Spectris (UK), METTLER TOLEDO International Inc., (US), Agilent Technologies, Inc. (US), Shimadzu Corporation (Japan), Hitachi High-Tech Corporation (Japan), Attana AB (Sweden), Bruker (US), NanoTemper Technologies GmbH (Germany), Affinitй Instruments (Canada), Biosensing Instrument (US), Unchained Labs (US), BioNavis Ltd. (Finland), Carterra, Inc. (US), Nicoya (Canada), BiOptix Analytical LLC (US), Plexera Bioscience (US), XanTec Bioanalytics GmbH (Germany), lino Biotech AG (Switzerland), and KEP Technologies (France)., and among others in the market.
1 INTRODUCTION

1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
  1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
  1.3.1 MARKETS COVERED
  1.3.2 YEARS CONSIDERED
  1.3.3 CURRENCY CONSIDERED
1.4 LIMITATIONS
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
  1.6.1 RECESSION IMPACT

2 RESEARCH METHODOLOGY

2.1 RESEARCH DATA
FIGURE 1 LABEL-FREE DETECTION MARKET: RESEARCH DESIGN
  2.1.1 SECONDARY RESEARCH
  2.1.2 PRIMARY RESEARCH
FIGURE 2 LABEL-FREE DETECTION MARKET: BREAKDOWN OF PRIMARIES
2.2 MARKET SIZE ESTIMATION
FIGURE 3 LABEL-FREE DETECTION MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2022
FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1—REVENUE SHARE ANALYSIS (2022)
FIGURE 5 KEY INDUSTRY INSIGHTS
2.3 GROWTH FORECAST
FIGURE 6 LABEL-FREE DETECTION MARKET: CAGR PROJECTIONS, 2023–2028
FIGURE 7 LABEL-FREE DETECTION MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 8 DATA TRIANGULATION METHODOLOGY
2.5 RESEARCH ASSUMPTIONS
2.6 RISK ANALYSIS
2.7 RECESSION IMPACT ANALYSIS
TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2027 (%GROWTH)
TABLE 2 US HEALTH EXPENDITURE, 2019–2022 (USD MILLION)
TABLE 3 US HEALTH EXPENDITURE, 2023–2030 (USD MILLION)

3 EXECUTIVE SUMMARY

FIGURE 9 LABEL-FREE DETECTION MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
FIGURE 10 LABEL-FREE DETECTION MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION)
FIGURE 11 LABEL-FREE DETECTION MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
FIGURE 12 LABEL-FREE DETECTION MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
FIGURE 13 GEOGRAPHICAL SNAPSHOT: LABEL-FREE DETECTION MARKET

4 PREMIUM INSIGHTS

4.1 LABEL-FREE DETECTION MARKET OVERVIEW
FIGURE 14 GROWING NUMBER OF DRUG DISCOVERY PROGRAMS TO DRIVE MARKET
4.2 NORTH AMERICA: LABEL-FREE DETECTION MARKET SHARE, BY PRODUCT & SERVICE AND COUNTRY (2022)
FIGURE 15 INSTRUMENTS DOMINATED NORTH AMERICAN LABEL-FREE DETECTION MARKET IN 2022
4.3 ASIA PACIFIC: LABEL-FREE DETECTION MARKET, BY END USER AND COUNTRY (2022)
FIGURE 16 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT ACCOUNTED FOR LARGEST SHARE OF APAC MARKET IN 2022
4.4 LABEL-FREE DETECTION MARKET SHARE, BY END USER, 2022
FIGURE 17 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
4.5 LABEL-FREE DETECTION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 18 ASIA PACIFIC COUNTRIES TO REGISTER HIGHEST GROWTH RATE IN LABEL-FREE DETECTION MARKET FROM 2023 TO 2028

5 MARKET OVERVIEW

5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 19 LABEL-FREE DETECTION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, CHALLENGES AND TRENDS
TABLE 4 LABEL-FREE DETECTION MARKET: IMPACT ANALYSIS
  5.2.1 DRIVERS
    5.2.1.1 Technological advancements in label-free detection
    5.2.1.2 Growing academic-industrial partnerships for drug discovery programs
    5.2.1.3 High sensitivity of label-free technologies
  5.2.2 RESTRAINTS
    5.2.2.1 High cost of instruments
  5.2.3 OPPORTUNITIES
    5.2.3.1 Growing life sciences research in emerging economies
  5.2.4 CHALLENGES
    5.2.4.1 Sample complexity and interference
  5.2.5 TRENDS
    5.2.5.1 Rising pharmaceutical outsourcing
    5.2.5.2 Increasing applications of label-free electrochemical sensing platforms
5.3 INDICATIVE PRICING ANALYSIS
TABLE 5 PRICING ANALYSIS FOR PRODUCTS
5.4 VALUE CHAIN ANALYSIS
FIGURE 20 VALUE CHAIN ANALYSIS: MANUFACTURING PHASES ADD MAXIMUM VALUE
5.5 ECOSYSTEM ANALYSIS
FIGURE 21 ECOSYSTEM ANALYSIS: LABEL-FREE DETECTION MARKET
TABLE 6 OVERALL MARKET ECOSYSTEM: ROLE OF KEY PLAYERS AND ENTITIES
5.6 PORTER’S FIVE FORCES ANALYSIS
TABLE 7 LABEL-FREE DETECTION MARKET: PORTER’S FIVE FORCES ANALYSIS
  5.6.1 THREAT OF NEW ENTRANTS
  5.6.2 THREAT OF SUBSTITUTES
  5.6.3 BARGAINING POWER OF BUYERS
  5.6.4 BARGAINING POWER OF SUPPLIERS
  5.6.5 INTENSITY OF COMPETITIVE RIVALRY
5.7 TECHNOLOGY ANALYSIS
TABLE 8 TECHNOLOGY ANALYSIS: BIOSENSOR ASSAYS VS. ISOTHERMAL TITRATION CALORIMETRY
5.8 PATENT ANALYSIS
FIGURE 22 TOP PATENT OWNERS IN LABEL-FREE DETECTION, JANUARY 2013– JULY 2023
5.9 REGULATORY SCENARIO ANALYSIS
  5.9.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 9 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 10 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 11 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 12 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 13 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.10 KEY CONFERENCES AND EVENTS IN 2023–2024
TABLE 14 LABEL-FREE DETECTION MARKET: LIST OF CONFERENCES AND EVENTS
5.11 KEY STAKEHOLDERS AND BUYING CRITERIA
  5.11.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF LABEL-FREE DETECTION TECHNOLOGIES
  5.11.2 BUYING CRITERIA FOR LABEL-FREE DETECTION PRODUCTS
FIGURE 24 KEY BUYING CRITERIA FOR END USERS

6 LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE

6.1 INTRODUCTION
TABLE 15 LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
6.2 INSTRUMENTS
  6.2.1 TECHNOLOGICAL ADVANCEMENTS IN LABEL-FREE DETECTION SYSTEMS TO DRIVE INSTRUMENTS MARKET
TABLE 16 LABEL-FREE DETECTION INSTRUMENTS OFFERED, BY COMPANY
TABLE 17 LABEL-FREE DETECTION INSTRUMENTS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 18 NORTH AMERICA: LABEL-FREE DETECTION INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 19 EUROPE: LABEL-FREE DETECTION INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 20 ASIA PACIFIC: LABEL-FREE DETECTION INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.3 CONSUMABLES
TABLE 21 LABEL-FREE DETECTION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 22 LABEL-FREE DETECTION CONSUMABLES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 23 NORTH AMERICA: LABEL-FREE DETECTION CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 24 EUROPE: LABEL-FREE DETECTION CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 25 ASIA PACIFIC: LABEL-FREE DETECTION CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  6.3.1 BIOSENSOR CHIPS
    6.3.1.1 High specificity and real-time monitoring to boost demand
TABLE 26 BIOSENSOR CHIPS OFFERED, BY COMPANY
TABLE 27 BIOSENSOR CHIPS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 28 NORTH AMERICA: BIOSENSOR CHIPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 29 EUROPE: BIOSENSOR CHIPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 30 ASIA PACIFIC: BIOSENSOR CHIPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  6.3.2 MICROPLATES
    6.3.2.1 Low cost and wide usage to drive market
TABLE 31 MICROPLATES OFFERED, BY COMPANY
TABLE 32 MICROPLATES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 33 NORTH AMERICA: MICROPLATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 34 EUROPE: MICROPLATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 35 ASIA PACIFIC: MICROPLATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  6.3.3 REAGENTS & KITS
    6.3.3.1 Availability of ready-to-use kits for assay development to drive market
TABLE 36 REAGENTS & KITS OFFERED, BY COMPANY
TABLE 37 REAGENTS & KITS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 38 NORTH AMERICA: REAGENTS & KITS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 39 EUROPE: REAGENTS & KITS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 40 ASIA PACIFIC: REAGENTS & KITS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.4 SOFTWARE & SERVICES
  6.4.1 AUTOMATION IN LABEL-FREE DETECTION TO DRIVE DEMAND
TABLE 41 SOFTWARE & SERVICES OFFERED, BY COMPANY
TABLE 42 LABEL-FREE DETECTION SOFTWARE & SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 43 NORTH AMERICA: LABEL-FREE DETECTION SOFTWARE & SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 44 EUROPE: LABEL-FREE DETECTION SOFTWARE & SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 45 ASIA PACIFIC: LABEL-FREE DETECTION SOFTWARE & SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)

7 LABEL-FREE DETECTION MARKET, BY TECHNOLOGY

7.1 INTRODUCTION
TABLE 46 LABEL-FREE DETECTION MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
7.2 SURFACE PLASMON RESONANCE
  7.2.1 GROWING USE OF SPR TECHNOLOGY IN AFFINITY AND KINETIC STUDIES TO FUEL MARKET GROWTH
TABLE 47 LABEL-FREE DETECTION MARKET FOR SURFACE PLASMON RESONANCE, BY REGION, 2021–2028 (USD MILLION)
TABLE 48 NORTH AMERICA: LABEL-FREE DETECTION MARKET FOR SURFACE PLASMON RESONANCE, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 49 EUROPE: LABEL-FREE DETECTION MARKET FOR SURFACE PLASMON RESONANCE, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 50 ASIA PACIFIC: LABEL-FREE DETECTION MARKET FOR SURFACE PLASMON RESONANCE, BY COUNTRY, 2021–2028 (USD MILLION)
7.3 DIFFERENTIAL SCANNING CALORIMETRY
  7.3.1 WIDE USAGE IN DRUG DISCOVERY AND DEVELOPMENT
TABLE 51 LABEL-FREE DETECTION MARKET FOR DIFFERENTIAL SCANNING CALORIMETRY, BY REGION, 2021–2028 (USD MILLION)
TABLE 52 NORTH AMERICA: LABEL-FREE DETECTION MARKET FOR DIFFERENTIAL SCANNING CALORIMETRY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 53 EUROPE: LABEL-FREE DETECTION MARKET FOR DIFFERENTIAL SCANNING CALORIMETRY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 54 ASIA PACIFIC: LABEL-FREE DETECTION MARKET FOR DIFFERENTIAL SCANNING CALORIMETRY, BY COUNTRY, 2021–2028 (USD MILLION)
7.4 BIO-LAYER INTERFEROMETRY
  7.4.1 MICROFLUIDICS-FREE CHARACTERISTIC TO BOOST ADOPTION
TABLE 55 LABEL-FREE DETECTION MARKET FOR BIO-LAYER INTERFEROMETRY, BY REGION, 2021–2028 (USD MILLION)
TABLE 56 NORTH AMERICA: LABEL-FREE DETECTION MARKET FOR BIO-LAYER INTERFEROMETRY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 57 EUROPE: LABEL-FREE DETECTION MARKET FOR BIO-LAYER INTERFEROMETRY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 58 ASIA PACIFIC: LABEL-FREE DETECTION MARKET FOR BIO-LAYER INTERFEROMETRY, BY COUNTRY, 2021–2028 (USD MILLION)
7.5 ISOTHERMAL TITRATION CALORIMETRY
  7.5.1 SUPPORT FOR BETTER HIT SELECTION AND LEAD OPTIMIZATION TO DRIVE ADOPTION
TABLE 59 LABEL-FREE DETECTION MARKET FOR ISOTHERMAL TITRATION CALORIMETRY, BY REGION, 2021–2028 (USD MILLION)
TABLE 60 NORTH AMERICA: LABEL-FREE DETECTION MARKET FOR ISOTHERMAL TITRATION CALORIMETRY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 61 EUROPE: LABEL-FREE DETECTION MARKET FOR ISOTHERMAL TITRATION CALORIMETRY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 62 ASIA PACIFIC: LABEL-FREE DETECTION MARKET FOR ISOTHERMAL TITRATION CALORIMETRY, BY COUNTRY, 2021–2028 (USD MILLION)
7.6 OTHER TECHNOLOGIES
TABLE 63 LABEL-FREE DETECTION MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2021–2028 (USD MILLION)
TABLE 64 NORTH AMERICA: LABEL-FREE DETECTION MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 65 EUROPE: LABEL-FREE DETECTION MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 66 ASIA PACIFIC: LABEL-FREE DETECTION MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION)

8 LABEL-FREE DETECTION MARKET, BY APPLICATION

8.1 INTRODUCTION
TABLE 67 LABEL-FREE DETECTION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
8.2 BINDING KINETICS
  8.2.1 BINDING KINETICS TO HOLD LARGEST MARKET SHARE TILL 2028
TABLE 68 LABEL-FREE DETECTION MARKET FOR BINDING KINETICS, BY REGION, 2021–2028 (USD MILLION)
TABLE 69 NORTH AMERICA: LABEL-FREE DETECTION MARKET FOR BINDING KINETICS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 70 EUROPE: LABEL-FREE DETECTION MARKET FOR BINDING KINETICS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 71 ASIA PACIFIC: LABEL-FREE DETECTION MARKET FOR BINDING KINETICS, BY COUNTRY, 2021–2028 (USD MILLION)
8.3 BINDING THERMODYNAMICS
  8.3.1 WIDE APPLICATIONS IN BASIC RESEARCH TO DRIVE MARKET
TABLE 72 LABEL-FREE DETECTION MARKET FOR BINDING THERMODYNAMICS, BY REGION, 2021–2028 (USD MILLION)
TABLE 73 NORTH AMERICA: LABEL-FREE DETECTION MARKET FOR BINDING THERMODYNAMICS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 74 EUROPE: LABEL-FREE DETECTION MARKET FOR BINDING THERMODYNAMICS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 75 ASIA PACIFIC: LABEL-FREE DETECTION MARKET FOR BINDING THERMODYNAMICS, BY COUNTRY, 2021–2028 (USD MILLION)
8.4 HIT CONFIRMATION
  8.4.1 NEED TO STUDY BIOMOLECULAR INTERACTIONS IN NATIVE STATES TO BOOST USAGE
TABLE 76 LABEL-FREE DETECTION MARKET FOR HIT CONFIRMATION, BY REGION, 2021–2028 (USD MILLION)
TABLE 77 NORTH AMERICA: LABEL-FREE DETECTION MARKET FOR HIT CONFIRMATION, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 78 EUROPE: LABEL-FREE DETECTION MARKET FOR HIT CONFIRMATION, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 79 ASIA PACIFIC: LABEL-FREE DETECTION MARKET FOR HIT CONFIRMATION, BY COUNTRY, 2021–2028 (USD MILLION)
8.5 LEAD GENERATION
  8.5.1 TECHNOLOGICAL ADVANCEMENTS TO DRIVE APPLICATIONS IN DRUG CANDIDATE SELECTION
TABLE 80 LABEL-FREE DETECTION MARKET FOR LEAD GENERATION, BY REGION, 2021–2028 (USD MILLION)
TABLE 81 NORTH AMERICA: LABEL-FREE DETECTION MARKET FOR LEAD GENERATION, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 82 EUROPE: LABEL-FREE DETECTION MARKET FOR LEAD GENERATION, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 83 ASIA PACIFIC: LABEL-FREE DETECTION MARKET FOR LEAD GENERATION, BY COUNTRY, 2021–2028 (USD MILLION)
8.6 ENDOGENOUS RECEPTOR DETECTION
  8.6.1 HIGH SENSITIVITY OF LABEL-FREE ASSAYS TO DRIVE ADOPTION
TABLE 84 LABEL-FREE DETECTION MARKET FOR ENDOGENOUS RECEPTOR DETECTION, BY REGION, 2021–2028 (USD MILLION)
TABLE 85 NORTH AMERICA: LABEL-FREE DETECTION MARKET FOR ENDOGENOUS RECEPTOR DETECTION, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 86 EUROPE: LABEL-FREE DETECTION MARKET FOR ENDOGENOUS RECEPTOR DETECTION, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 87 ASIA PACIFIC: LABEL-FREE DETECTION MARKET FOR ENDOGENOUS RECEPTOR DETECTION, 2021–2028 (USD MILLION)
8.7 OTHER APPLICATIONS
TABLE 88 LABEL-FREE DETECTION MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
TABLE 89 NORTH AMERICA: LABEL-FREE DETECTION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 90 EUROPE: LABEL-FREE DETECTION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 91 ASIA PACIFIC: LABEL-FREE DETECTION MARKET FOR OTHER APPLICATIONS, 2021–2028 (USD MILLION)

9 LABEL-FREE DETECTION MARKET, BY END USER

9.1 INTRODUCTION
TABLE 92 LABEL-FREE DETECTION MARKET, BY END USER, 2021–2028 (USD MILLION)
9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  9.2.1 PHARMA & BIOTECH COMPANIES TO HOLD LARGEST MARKET SHARE TILL 2028
TABLE 93 LABEL-FREE DETECTION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION)
TABLE 94 NORTH AMERICA: LABEL-FREE DETECTION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 95 EUROPE: LABEL-FREE DETECTION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 96 ASIA PACIFIC: LABEL-FREE DETECTION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
9.3 ACADEMIC & RESEARCH INSTITUTES
  9.3.1 RISING INDUSTRY-ACADEMIA RESEARCH COLLABORATIONS TO DRIVE MARKET
TABLE 97 LABEL-FREE DETECTION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION)
TABLE 98 NORTH AMERICA: LABEL-FREE DETECTION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 99 EUROPE: LABEL-FREE DETECTION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 100 ASIA PACIFIC: LABEL-FREE DETECTION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
9.4 CONTRACT RESEARCH ORGANIZATIONS
  9.4.1 INCREASING PHARMACEUTICAL OUTSOURCING TO DRIVE MARKET GROWTH
TABLE 101 LABEL-FREE DETECTION MARKET FOR CROS, BY REGION, 2021–2028 (USD MILLION)
TABLE 102 NORTH AMERICA: LABEL-FREE DETECTION MARKET FOR CROS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 103 EUROPE: LABEL-FREE DETECTION MARKET FOR CROS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 104 ASIA PACIFIC: LABEL-FREE DETECTION MARKET FOR CROS, BY COUNTRY, 2021–2028 (USD MILLION)
9.5 OTHER END USERS
TABLE 105 LABEL-FREE DETECTION MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION)
TABLE 106 NORTH AMERICA: LABEL-FREE DETECTION MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 107 EUROPE: LABEL-FREE DETECTION MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 108 ASIA PACIFIC: LABEL-FREE DETECTION MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)

10 LABEL-FREE DETECTION MARKET, BY REGION

10.1 INTRODUCTION
TABLE 109 LABEL-FREE DETECTION MARKET, BY REGION, 2021–2028 (USD MILLION)
10.2 NORTH AMERICA
  10.2.1 NORTH AMERICA: RECESSION IMPACT
FIGURE 25 NORTH AMERICA: LABEL-FREE DETECTION MARKET SNAPSHOT
TABLE 110 NORTH AMERICA: LABEL-FREE DETECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 111 NORTH AMERICA: LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 112 NORTH AMERICA: LABEL-FREE DETECTION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 113 NORTH AMERICA: LABEL-FREE DETECTION MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 114 NORTH AMERICA: LABEL-FREE DETECTION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 115 NORTH AMERICA: LABEL-FREE DETECTION MARKET, BY END USER, 2021–2028 (USD MILLION)
  10.2.2 US
    10.2.2.1 US to dominate label-free detection market in North America
TABLE 116 US: LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 117 US: LABEL-FREE DETECTION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 118 US: LABEL-FREE DETECTION MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 119 US: LABEL-FREE DETECTION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 120 US: LABEL-FREE DETECTION MARKET, BY END USER, 2021–2028 (USD MILLION)
  10.2.3 CANADA
    10.2.3.1 Government initiatives to promote research to support market growth
TABLE 121 CANADA: LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 122 CANADA: LABEL-FREE DETECTION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 123 CANADA: LABEL-FREE DETECTION MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 124 CANADA: LABEL-FREE DETECTION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 125 CANADA: LABEL-FREE DETECTION MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3 EUROPE
  10.3.1 EUROPE: RECESSION IMPACT
TABLE 126 EUROPE: LABEL-FREE DETECTION MARKET BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 127 EUROPE: LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 128 EUROPE: LABEL-FREE DETECTION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 129 EUROPE: LABEL-FREE DETECTION MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 130 EUROPE: LABEL-FREE DETECTION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 131 EUROPE: LABEL-FREE DETECTION MARKET, BY END USER, 2021–2028 (USD MILLION)
  10.3.2 GERMANY
    10.3.2.1 Germany to dominate European label-free detection market
TABLE 132 GERMANY: LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 133 GERMANY: LABEL-FREE DETECTION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 134 GERMANY: LABEL-FREE DETECTION MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 135 GERMANY: LABEL-FREE DETECTION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 136 GERMANY: LABEL-FREE DETECTION MARKET, BY END USER, 2021–2028 (USD MILLION)
  10.3.3 UK
    10.3.3.1 Government and private sponsorships for drug discovery services to support market
TABLE 137 UK: LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 138 UK: LABEL-FREE DETECTION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 139 UK: LABEL-FREE DETECTION MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 140 UK: LABEL-FREE DETECTION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 141 UK: LABEL-FREE DETECTION MARKET, BY END USER, 2021–2028 (USD MILLION)
  10.3.4 FRANCE
    10.3.4.1 Favorable funding scenario to drive market
TABLE 142 FRANCE: LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 143 FRANCE: LABEL-FREE DETECTION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 144 FRANCE: LABEL-FREE DETECTION MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 145 FRANCE: LABEL-FREE DETECTION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 146 FRANCE: LABEL-FREE DETECTION MARKET, BY END USER, 2021–2028 (USD MILLION)
  10.3.5 ITALY
    10.3.5.1 Rising life science R&D to drive market
TABLE 147 ITALY: LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 148 ITALY: LABEL-FREE DETECTION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 149 ITALY: LABEL-FREE DETECTION MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 150 ITALY: LABEL-FREE DETECTION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 151 ITALY: LABEL-FREE DETECTION MARKET, BY END USER, 2021–2028 (USD MILLION)
  10.3.6 SPAIN
    10.3.6.1 Increasing focus on personalized medicines to drive market
TABLE 152 SPAIN: LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 153 SPAIN: LABEL-FREE DETECTION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 154 SPAIN: LABEL-FREE DETECTION MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 155 SPAIN: LABEL-FREE DETECTION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 156 SPAIN: LABEL-FREE DETECTION MARKET, BY END USER, 2021–2028 (USD MILLION)
  10.3.7 REST OF EUROPE
TABLE 157 REST OF EUROPE: LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 158 REST OF EUROPE: LABEL-FREE DETECTION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 159 REST OF EUROPE: LABEL-FREE DETECTION MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 160 REST OF EUROPE: LABEL-FREE DETECTION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 161 REST OF EUROPE: LABEL-FREE DETECTION MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4 ASIA PACIFIC
  10.4.1 ASIA PACIFIC: RECESSION IMPACT
TABLE 162 ASIA PACIFIC: LABEL-FREE DETECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 163 ASIA PACIFIC: LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 164 ASIA PACIFIC: LABEL-FREE DETECTION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 165 ASIA PACIFIC: LABEL-FREE DETECTION MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 166 ASIA PACIFIC: LABEL-FREE DETECTION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 167 ASIA PACIFIC: LABEL-FREE DETECTION MARKET, BY END USER, 2021–2028 (USD MILLION)
  10.4.2 CHINA
    10.4.2.1 China to dominate APAC label-free detection market
TABLE 168 CHINA: LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 169 CHINA: LABEL-FREE DETECTION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 170 CHINA: LABEL-FREE DETECTION MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 171 CHINA: LABEL-FREE DETECTION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 172 CHINA: LABEL-FREE DETECTION MARKET, BY END USER, 2021–2028 (USD MILLION)
  10.4.3 JAPAN
    10.4.3.1 Robust funding for research to propel market growth
TABLE 173 JAPAN: LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 174 JAPAN: LABEL-FREE DETECTION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 175 JAPAN: LABEL-FREE DETECTION MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 176 JAPAN: LABEL-FREE DETECTION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 177 JAPAN: LABEL-FREE DETECTION MARKET, BY END USER, 2021–2028 (USD MILLION)
  10.4.4 INDIA
    10.4.4.1 Growing R&D spending by pharma companies and favorable government initiatives to support adoption
TABLE 178 INDIA: LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 179 INDIA: LABEL-FREE DETECTION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 180 INDIA: LABEL-FREE DETECTION MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 181 INDIA: LABEL-FREE DETECTION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 182 INDIA: LABEL-FREE DETECTION MARKET, BY END USER, 2021–2028 (USD MILLION)
  10.4.5 REST OF ASIA PACIFIC
TABLE 183 REST OF ASIA PACIFIC: LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 184 REST OF ASIA PACIFIC: LABEL-FREE DETECTION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 185 REST OF ASIA PACIFIC: LABEL-FREE DETECTION MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 186 REST OF ASIA PACIFIC: LABEL-FREE DETECTION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 187 REST OF ASIA PACIFIC: LABEL-FREE DETECTION MARKET, BY END USER, 2021–2028 (USD MILLION)
10.5 LATIN AMERICA
  10.5.1 RISING ADOPTION OF LABEL-FREE DETECTION TECHNOLOGIES IN BIOTECH & PHARMA SECTORS TO SUPPORT GROWTH
  10.5.2 LATIN AMERICA: RECESSION IMPACT
TABLE 188 LATIN AMERICA: LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 189 LATIN AMERICA: LABEL-FREE DETECTION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 190 LATIN AMERICA: LABEL-FREE DETECTION MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 191 LATIN AMERICA: LABEL-FREE DETECTION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 192 LATIN AMERICA: LABEL-FREE DETECTION MARKET, BY END USER, 2021–2028 (USD MILLION)
10.6 MIDDLE EAST & AFRICA
  10.6.1 GROWING PHARMACEUTICAL INDUSTRY TO DRIVE MARKET
  10.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
TABLE 193 MIDDLE EAST & AFRICA: LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 194 MIDDLE EAST & AFRICA: LABEL-FREE DETECTION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 195 MIDDLE EAST & AFRICA: LABEL-FREE DETECTION MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 196 MIDDLE EAST & AFRICA: LABEL-FREE DETECTION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 197 MIDDLE EAST & AFRICA: LABEL-FREE DETECTION MARKET, BY END USER, 2021–2028 (USD MILLION)

11 COMPETITIVE LANDSCAPE

11.1 INTRODUCTION
11.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS
FIGURE 26 LABEL-FREE DETECTION MARKET: STRATEGIES ADOPTED BY KEY PLAYERS, 2020-2023
11.3 MARKET SHARE ANALYSIS
FIGURE 27 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2022
TABLE 198 LABEL-FREE DETECTION MARKET: DEGREE OF COMPETITION
11.4 REVENUE SHARE ANALYSIS
FIGURE 28 REVENUE ANALYSIS OF KEY PLAYERS, 2020–2022
11.5 COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022
FIGURE 29 LABEL-FREE DETECTION MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022
  11.5.1 STARS
  11.5.2 EMERGING LEADERS
  11.5.3 PERVASIVE PLAYERS
  11.5.4 PARTICIPANTS
11.6 COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS
  11.6.1 COMPANY PRODUCT FOOTPRINT (25 COMPANIES)
TABLE 199 PRODUCT FOOTPRINT ANALYSIS
  11.6.2 COMPANY REGIONAL FOOTPRINT (25 COMPANIES)
TABLE 200 REGIONAL FOOTPRINT ANALYSIS
11.7 COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022
FIGURE 30 LABEL-FREE DETECTION MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022
  11.7.1 PROGRESSIVE COMPANIES
  11.7.2 RESPONSIVE COMPANIES
  11.7.3 DYNAMIC COMPANIES
  11.7.4 STARTING BLOCKS
11.8 COMPETITIVE BENCHMARKING OF START-UP/SME PLAYERS
TABLE 201 LABEL-FREE DETECTION MARKET: DETAILED LIST OF KEY START-UP/SME PLAYERS
TABLE 202 LABEL-FREE DETECTION MARKET: COMPETITIVE BENCHMARKING OF START-UP/SME PLAYERS
11.9 COMPETITIVE SCENARIO AND TRENDS
  11.9.1 PRODUCT LAUNCHES
TABLE 203 LABEL-FREE DETECTION MARKET: PRODUCT LAUNCHES, JANUARY 2020–JUNE 2023
  11.9.2 DEALS
TABLE 204 LABEL-FREE DETECTION MARKET: DEALS, JANUARY 2020–JUNE 2023
  11.9.3 OTHER DEVELOPMENTS
TABLE 205 LABEL-FREE DETECTION MARKET: OTHER DEVELOPMENTS, JANUARY 2020–JUNE 2023

12 COMPANY PROFILES

12.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
  12.1.1 DANAHER
TABLE 206 DANAHER: BUSINESS OVERVIEW
FIGURE 31 DANAHER: COMPANY SNAPSHOT (2022)
  12.1.2 SARTORIUS AG
TABLE 207 SARTORIUS AG: BUSINESS OVERVIEW
FIGURE 32 SARTORIUS AG: COMPANY SNAPSHOT (2022)
  12.1.3 WATERS CORPORATION
TABLE 208 WATERS CORPORATION: BUSINESS OVERVIEW
FIGURE 33 WATERS: COMPANY SNAPSHOT (2022)
  12.1.4 PERKINELMER, INC.
TABLE 209 PERKINELMER, INC.: BUSINESS OVERVIEW
FIGURE 34 PERKINELMER, INC.: COMPANY SNAPSHOT (2022)
  12.1.5 AMETEK, INC.
TABLE 210 AMETEK, INC.: BUSINESS OVERVIEW
FIGURE 35 AMETEK, INC.: COMPANY SNAPSHOT (2022)
  12.1.6 HORIBA, LTD.
TABLE 211 HORIBA, LTD.: BUSINESS OVERVIEW
FIGURE 36 HORIBA, LTD.: COMPANY SNAPSHOT (2022)
  12.1.7 SPECTRIS
TABLE 212 SPECTRIS: BUSINESS OVERVIEW
FIGURE 37 SPECTRIS: COMPANY SNAPSHOT
  12.1.8 METTLER TOLEDO INTERNATIONAL, INC.
TABLE 213 METTLER TOLEDO INTERNATIONAL, INC.: BUSINESS OVERVIEW
FIGURE 38 METTLER TOLEDO INTERNATIONAL, INC.: COMPANY SNAPSHOT (2022)
  12.1.9 AGILENT TECHNOLOGIES, INC.
TABLE 214 AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW
FIGURE 39 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2022)
  12.1.10 SHIMADZU CORPORATION
TABLE 215 SHIMADZU CORPORATION: BUSINESS OVERVIEW
FIGURE 40 SHIMADZU CORPORATION: COMPANY SNAPSHOT (2022)
  12.1.11 HITACHI HIGH-TECH CORPORATION
TABLE 216 HITACHI HIGH-TECH CORPORATION: BUSINESS OVERVIEW
FIGURE 41 HITACHI HIGH-TECH CORPORATION: COMPANY SNAPSHOT (2022)
  12.1.12 ATTANA AB
TABLE 217 ATTANA AB: BUSINESS OVERVIEW
FIGURE 42 ATTANA AB: COMPANY SNAPSHOT (2022)
  12.1.13 BRUKER
TABLE 218 BRUKER: BUSINESS OVERVIEW
FIGURE 43 BRUKER: COMPANY SNAPSHOT (2022)
12.2 OTHER PLAYERS
  12.2.1 NANOTEMPER TECHNOLOGIES GMBH
  12.2.2 AFFINITЙ INSTRUMENTS
  12.2.3 BIOSENSING INSTRUMENT
  12.2.4 UNCHAINED LABS
  12.2.5 BIONAVIS LTD.
  12.2.6 CARTERRA, INC.
  12.2.7 NICOYA
  12.2.8 BIOPTIX ANALYTICAL LLC
  12.2.9 PLEXERA BIOSCIENCE
  12.2.10 XANTEC BIOANALYTICS GMBH
  12.2.11 LINO BIOTECH AG (MILTENYI BIOTEC)
  12.2.12 KEP TECHNOLOGIES
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

13 APPENDIX

13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS


More Publications